Robustness, Scalability, and Integration of
a Wound-Reponse Gene Expression Signature in Predicting Breast
Cancer Survival
Robustness, Scalability, and Integration of
a Wound-Reponse Gene Expression Signature in Predicting Breast
Cancer Survival
Howard Y. Chang, Dimitry S.A. Nuyten, Julie B. Sneddon, Trevor Hastie, Robert Tibshirani, Therese Sorlie, Hongyue Dai, Yudong He, Laura van't Veer, Harry Bartelink, Matt van de Rijn, Patrick O. Brown, Marc J. van de Vijver
| Home |
| Authors |
|
Authors Howard Y. Chang*1,2, Dimitry S.A. Nuyten*6,7, Julie B. Sneddon2, Trevor Hastie3, Robert Tibshirani3, Therese Sorlie2,9, Hongyue Dai8, Yudong He8, Laura van't Veer, Harry Bartelink7, Matt van de Rijn4, Patrick O. Brown2,5, Marc J. van de Vijver6
*H.Y.C. and D.S.A.N. contributed equally and share first authorship.
1. Program in Epithelial Biology, Stanford University School of Medicine, Stanford, CA, 94305, USA. 2. Department of Biochemistry, Stanford University School of Medicine, Stanford, CA, 94305, USA. 3. Health Research and Policy, Stanford University School of Medicine, Stanford, CA, 94305, USA. 4. Department of Pathology, Stanford University School of Medicine, Stanford, CA, 94305, USA. 5. Howard Hughes Medical Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA. 6. Diagnostic Oncology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. 7. Radiation Oncology, the Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, The Netherlands. 8. Rosetta Inpharmatics, Seattle, WA, 98109. 9. Norwegian Radium Hospital, 0310 Oslo, Norway.
Last edited by Julie B. Sneddon on January 24, 2005 |